Semaglutide has a well-established safety profile in people with T2D and obesity, including in people aged 65 years and older, suggesting that it will be well tolerated in the evoke/evoke+ populations with early AD [15, 27, 41,42,43,44, 57, 58, 63]
And are you educating them on the risks that are inherent in this choice? &
Instead, work with your PlexusDx team to slow your dose increase, maintain your current dose longer, or switch to an alternative GLP-1 compound like tirzepatide if joint symptoms persist
Aloin protects against chronic alcoholic liver injury via attenuating lipid accumulation, oxidative stress and inflammation in mice
Oxidative stress is what happens when reactive molecules collectively called reactive oxygen species accumulate faster than your antioxidant systems can neutralize them
Nonetheless, the long-term consequences of GLP-1 RA use in adolescents remain under-researched, highlighting the need for future studies on safety and effectiveness in adolescent populations
